2023
DOI: 10.1007/s00296-023-05403-5
|View full text |Cite
|
Sign up to set email alerts
|

Multi-disciplinary community-based group intervention for fibromyalgia: a pilot randomized controlled trial

Abstract: Fibromyalgia is characterized by widespread pain, fatigue, sleep disturbances, mood disturbances, and cognitive impairment. Most individuals with fibromyalgia experience poorly managed symptoms and increased healthcare service use. Multicomponent therapies, with a focus on nonpharmacological modalities, are increasingly supported in the literature. However, given the limited resources available, implementation in smaller communities remains a challenge. This research tested a community-based multidisciplinary … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…Most treatments for FM patients address pain, imbalance, and sleep disorders. However, a few studies proposed to follow a program for resilience and sense of coherence among patients [58,59].…”
Section: Discussionmentioning
confidence: 99%
“…Most treatments for FM patients address pain, imbalance, and sleep disorders. However, a few studies proposed to follow a program for resilience and sense of coherence among patients [58,59].…”
Section: Discussionmentioning
confidence: 99%
“…Multicomponent treatments are currently considered the "gold standard" along with maintaining individualized care [3]. Recent quantitative studies are confirming the effectiveness of some multicomponent treatments for FM patients [6,8,[25][26][27]. It is essential that strategies be tested to promote equality of care across different settings.…”
Section: Discussionmentioning
confidence: 99%
“…The management of fibromyalgia typically necessitates a comprehensive strategy including multiple disciplines and should be customized to address the specific symptoms and requirements of each individual [ 7 ]. Depending on the clinician’s preference and the patient’s compliance, pharmacological agents such as tricyclic antidepressants, serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and gabapentinoid drugs (GDs) are used in the treatment [ 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%